buthionine sulfoximine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayward, A; Lee, A; Morocutti, A; Sethi, M; Viberti, G | 1 |
1 other study(ies) available for buthionine sulfoximine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Glutathione reverses the growth abnormalities of skin fibroblasts from insulin-dependent diabetic patients with nephropathy.
Topics: Adult; Aged; Buthionine Sulfoximine; Cell Division; Cells, Cultured; Culture Media; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Fibroblasts; Glucose; Glutathione; Humans; Male; Middle Aged; Skin; Superoxide Dismutase | 1998 |